These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8134299

  • 1. Sympathetic thyroidal vasoconstriction is not blocked by a neuropeptide Y antagonist or antiserum.
    Dey M, Michalkiewicz M, Huffman L, Hedge GA.
    Peptides; 1993; 14(6):1179-86. PubMed ID: 8134299
    [Abstract] [Full Text] [Related]

  • 2. NPY is not a primary mediator of the acute thyroid blood flow response to sympathetic nerve stimulation.
    Dey M, Michalkiewicz M, Huffman L, Hedge GA.
    Am J Physiol; 1993 Jul; 265(1 Pt 1):E24-30. PubMed ID: 8338150
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V, Edvinsson L, Burnstock G.
    Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
    [Abstract] [Full Text] [Related]

  • 4. Endogenous neuropeptide Y regulates thyroid blood flow.
    Michalkiewicz M, Huffman LJ, Dey M, Hedge GA.
    Am J Physiol; 1993 May; 264(5 Pt 1):E699-705. PubMed ID: 8498492
    [Abstract] [Full Text] [Related]

  • 5. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S, Yang CL, Chen X, Naes L, Cox BF, Westfall T.
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [Abstract] [Full Text] [Related]

  • 6. Noradrenergic and peptidergic sympathetic regulation of cutaneous microcirculation in the rat.
    Pintér E, Helyes Z, Pethö G, Szolcsányi J.
    Eur J Pharmacol; 1997 Apr 23; 325(1):57-64. PubMed ID: 9151939
    [Abstract] [Full Text] [Related]

  • 7. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH, Hjemdahl P.
    J Cardiovasc Pharmacol; 1993 Mar 23; 21(3):347-52. PubMed ID: 7681493
    [Abstract] [Full Text] [Related]

  • 8. The neuropeptides, VIP and NPY, that are present in the thyroid nerves are not released into the thyroid vein.
    Michalkiewicz M, Dey M, Huffman LJ, Hedge GA.
    Thyroid; 1998 Nov 23; 8(11):1071-7. PubMed ID: 9848726
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM, Modin A.
    Br J Pharmacol; 1995 Dec 23; 116(7):2971-82. PubMed ID: 8680732
    [Abstract] [Full Text] [Related]

  • 10. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
    Kim SK, Ang L, Hsu YY, Dörscher-Kim J, Kim S.
    Arch Oral Biol; 1996 Dec 23; 41(8-9):791-8. PubMed ID: 9022916
    [Abstract] [Full Text] [Related]

  • 11. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
    Pernow J, Modin A, Lundberg JM.
    Eur J Pharmacol; 1992 Nov 03; 222(1):171-4. PubMed ID: 1468494
    [Abstract] [Full Text] [Related]

  • 12. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF, Sawin LL.
    J Lab Clin Med; 2001 Aug 03; 138(2):119-29. PubMed ID: 11477379
    [Abstract] [Full Text] [Related]

  • 13. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
    Sun X, You J, Hedner T, Erlinge D, Fellström B, Yoo H, Wahlestedt C, Edvinsson L.
    J Pharm Pharmacol; 1996 Jan 03; 48(1):77-84. PubMed ID: 8722501
    [Abstract] [Full Text] [Related]

  • 14. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J, Benjamin N, Larkin S, Webb D, Maseri A, Davies G.
    Circulation; 1991 Mar 03; 83(3):774-7. PubMed ID: 1999028
    [Abstract] [Full Text] [Related]

  • 15. Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
    Bradley E, Law A, Bell D, Johnson CD.
    Am J Physiol Heart Circ Physiol; 2003 Jun 03; 284(6):H2007-14. PubMed ID: 12742824
    [Abstract] [Full Text] [Related]

  • 16. A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP).
    Wahlestedt C, Reis DJ, Yoo H, Adamsson M, Andersson D, Edvinsson L.
    Neurosci Lett; 1992 Aug 31; 143(1-2):123-6. PubMed ID: 1436655
    [Abstract] [Full Text] [Related]

  • 17. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N, Yang T, Levy MN.
    Circ Res; 1993 Apr 31; 72(4):816-26. PubMed ID: 8443869
    [Abstract] [Full Text] [Related]

  • 18. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y.
    Modin A, Pernow J, Lundberg JM.
    Acta Physiol Scand; 1993 May 31; 148(1):1-11. PubMed ID: 8333291
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat.
    Edwall B, Gazelius B, Fazekas A, Theodorsson-Norheim E, Lundberg JM.
    Acta Physiol Scand; 1985 Oct 31; 125(2):253-64. PubMed ID: 2866663
    [Abstract] [Full Text] [Related]

  • 20. Sympathetic vascular control of the laryngeo-tracheal, bronchial and pulmonary circulation in the pig: evidence for non-adrenergic mechanisms involving neuropeptide Y.
    Franco-Cereceda A, Matran R, Alving K, Lundberg JM.
    Acta Physiol Scand; 1995 Oct 31; 155(2):193-204. PubMed ID: 8669292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.